PRIVACY POLICY

Effective Date: September 10, 2020

Enosi Life Sciences Corp. is a drug research and development company focused on providing industry-leading therapeutics for autoimmune diseases and cancer (“Company”, “we” or “our”). In this Privacy Policy, we describe how we collect, use, and disclose personal information that we obtain from visitors to our site.

The Information We Collect About You

We collect personal information directly from you, third parties and automatically through your use of our site.

Information We Collect Directly From You. The type of information that we collect from you depends upon your interaction with us. We collect the specific personal information you furnish to us such as your email and other contact information.

Information We Collect Automatically. We automatically collect the following information about your use of our site through cookies, web beacons, and other technologies: your domain name; your browser type and operating system; web pages you view; links you click; your IP address; the length of time you visit our site; and the referring URL, or the webpage that led you to our site.  We may combine this information with other information that we have collected about you. 

How We Use Your Information

We use your information, including your personal information, for the following purposes:

  • To communicate with you and provide our newsletters or updates,
  • To respond to your inquiries and for other similar purposes,
  • To tailor the content and information that we may send or display to you and to personalize your experiences while using the site,
  • To improve our site and for other internal business purposes, including detecting security incidents, identifying and repairing errors,
  • To better understand how users access and use our site, both on an aggregated and individualized basis, in order to improve our site and respond to user preferences, and for other research and analytical purposes,
  • To enable you to learn about and invest in our Company, and
  • Other purposes we may notify you of or which are apparent from our interaction with you.

How We Share Your Information

We may share your information, including personal information, as follows:

  • Service Providers. We may disclose personal information with service providers who use this information to perform services for us, such as hosting providers, auditors, financial, legal and other advisors, consultants, and/or support providers.
  • Third Parties. To learn more about investing in our Company, we use a third party company, DealMaker, and you may choose to provide your email address, name, phone number, and other information to create an account with them. Please review their privacy policy and terms for more information.
  • Affiliates. We may disclose the personal information we collect from you to our affiliates or subsidiaries.
  • Business Transfers. If we or our assets are acquired by, transferred to or merged with another company or as part of a bankruptcy proceeding, we may transfer the information we have collected from you to the other company.
  • In Response to Legal Process. We may disclose the information we collect from you in order to comply with the law, a judicial proceeding, court order, or other legal process, such as in response to a court order or a subpoena.
  • To Protect Us and Others. We may disclose the information we collect from you where we believe it is necessary to investigate, prevent, or take action regarding illegal activities, suspected fraud, situations involving potential threats to the safety or security of any person or us, and violations of our terms or this Privacy Policy.
  • Aggregated and De-Identified Information. We may share aggregated or de-identified information about users with third parties for marketing, advertising, research or other purposes.

Cookies and Other Tracking Mechanisms

We and our service providers use cookies and other tracking mechanisms to track information about your use of our site. We may combine this information with other personal information we collect from you.

Cookies.  Cookies are alphanumeric identifiers that we transfer to your computer’s hard drive through your web browser for record-keeping purposes. Some cookies allow us to make it easier for you to navigate our site while others are used to enable a faster log-in process or to allow us to track your activities at our site. Most web browsers automatically accept cookies. The Help portion of the toolbar on most browsers will tell you how manage cookies or disable certain cookies. Visitors to our site who disable cookies will be able to browse certain areas of the site, but some features may not function.

Pixel tags. Pixel tags are tiny graphics with a unique identifier, similar in function to cookies. But unlike cookies, which are stored on your computer’s hard drive, pixel tags are embedded invisibly on web pages. We may use these to track the activities of users, personalize and manage content, and gather usage information about our site. We may also use these in HTML emails to, to help us track email response rates, identify when our emails are viewed, and track whether our emails are forwarded.

Do-Not-Track.  Currently, our systems do not recognize browser “do-not-track” requests. You may, however, disable certain tracking as discussed in this section (e.g., by disabling cookies).

Third-Party Analytics. Our site may use services operated by third parties, such as Google Analytics, which use cookies and similar technologies to collect and analyze information about use of the site and report on activities and trends. You can learn about Google’s practices by going to www.google.com/policies/privacy/partners/, and you can opt out by downloading the Google Analytics opt-out browser add-on available at https://tools.google.com/dlpage/gaoptout

Social Plugins and Links. We may link to or use social plugins such as Facebook, LinkedIn or Instagram on our site. When you view a site that contains a plugin, your browser will create a direct link to the third parties’ servers. If you are logged into your social media account, the social media platform will record the visit to your social media account. Please visit the social media platform’s privacy policy for more information.

Third-Party Ad Networks. We use third parties such as network advertisers to serve advertisements on our site and on third-party websites or other media (e.g., social networking platforms). This enables us and these third parties to target advertisements to you for opportunities or content in which you might be interested. Third-party ad network providers, advertisers, sponsors and/or traffic measurement services may use cookies, JavaScript, web beacons (including clear GIFs), and other tracking technologies to measure the effectiveness of their ads and to personalize advertising content to you. These third-party cookies and other technologies are governed by each third party’s specific privacy policy, not this one. We may provide these third-party advertisers with information, including personal information, about you.

Users in the United States may opt out of many third-party ad networks. For example, you may go to the Digital Advertising Alliance (DAA) Consumer Choice Page for information about opting out of interest-based advertising and your choices.

Opting out from one or more companies listed on the DAA Consumer Choice Page will opt you out from those companies’ delivery of interest-based content or ads to you, but it does not mean you will no longer receive any advertising through our site or on other websites. You may continue to receive advertisements, for example, based on the particular website that you are viewing (i.e., contextually based ads). Also, if your browsers are configured to reject cookies when you opt out on the DAA site, your opt out may not be effective. Additional information is available on the DAA’s website at www.aboutads.info.

Third-Party Links

Our site may contain links to third-party websites. Those sites are governed by their own  privacy policies. We are not responsible for their information practices.

Data Transfers

We may transfer the personal information we collect to the United States and other countries, which may have different data protection laws than your country. If we do so, we will transfer the personal information only for the purposes described in this Privacy Policy. When we transfer your personal information to recipients in other countries, we will take appropriate measures to protect that information to the extent required by applicable law.

Retention of Personal Information

To the extent permitted by applicable law, we retain personal information we obtain about you for as long as it is needed for the purposes for which it was collected as described in this Privacy Policy and to comply with applicable laws, resolve disputes, enforce our agreements, and to fulfill regulatory obligations.

Security of My Personal Information

We have implemented commercially reasonable precautions to protect the information we collect from loss, misuse, and unauthorized access, disclosure, alteration, and destruction. Please be aware that despite these measures, no data security measures can guarantee 100% security.

You should take steps to protect against unauthorized access to your password, phone, and computer by, among other things, signing off after using a shared computer, choosing a robust password that nobody else knows or can easily guess, and keeping your log-in and password private. We are not responsible for any lost, stolen, or compromised passwords or for any activity on your account via unauthorized password activity.

Your Choices

To modify your e-mail preferences, please opt out using the unsubscribe link in the email or let us know by contacting us as described below.

Children

Our site is not designed for children. If we discover that a child has provided us with personal information, we will delete such information from our systems.

Changes to this Privacy Policy

This Privacy Policy is current as of the Effective Date above. We may change this Privacy Policy from time to time so please be sure to check back periodically.

Contact

If you have questions about our privacy practices or would like to make a complaint, please contact us at 12707 High Bluff Drive, Suite 200, San Diego, California, 92130-2035, United States of America, 1 (858) 350 4392 or [email protected]k.

James N. Woody

James N. Woody

Executive Chairman

  • Jim brings more than 25 years of pharmaceutical research and management experience to Enosi.
  • In addition to his duties as a consultant to LVP, where he served as a General Partner for 14 years, Jim is currently Chairman of Viracta Therapeutics, a company focusing on unique therapies for virally induced cancers.  
  • He was the founding CEO of OncoMed Pharmaceuticals, a cancer therapeutic antibody company. He was the Board member for both ForteBio, and Protein Simple, both successfully acquired. Jim was formerly President and GM of Roche Bioscience (former Syntex) in Palo Alto, CA. 
  • Previously, Jim served as Chief Scientific Officer and Senior Vice President of R&D for Centocor. While at Centocor, Jim’s team developed the blockbuster drug Remicade. 
  • Jim served as a Navy Medical Officer, and was Head of the Navy Transplant Research Program. With his colleagues and with both Navy and Congressional support, founded the National Marrow Donor Program. 
  • He was promoted to Commanding Officer and Director, US Naval Medical Research and Development Command in Bethesda Maryland. He was responsible for the surveillance, detection and therapy for all Biologic Warfare Agents and Infectious Diseases in the first Gulf War and was awarded the Marine Corps/US Navy Legion of Merit for his service. 
  • Jim served as Chairman of the Silicon Valley Leadership Group representing over 120 Silicon Valley Companies, is a board member of the Lucile Packard Children’s Hospital (Stanford).
  • Jim holds an M.D. from Loma Linda University, trained in Pediatric Immunology at Duke University and Children’s Hospital in Boston (Harvard), and holds a Ph.D. in Immunology from the University of London, England. He was Professor of Pediatrics and Microbiology at Georgetown University School of Medicine 1982-1996. He has authored or co-authored over 140 publications.
Dr. H. Michael Shepard

H. Michael Shepard, Ph.D.

CEO & Co-founder

  • Dr. H. Michael Shepard is a global, leading authority on cancer research and therapeutics.
  • Best known for his invention of “Herceptin”/Trastuzumab, which has remained one of the most profitable platforms for Roche (>$7B USD).
  • Dr. Shepard is a highly-experienced and respected leader with many successful ventures in this field – working at Genentech (sold to Roche – $46.8 B USD), Canji, Inc. (bought by Scheirng-Plough) and Halozyme (now valued at $2.6B USD).
  • Widely acknowledged biomarker pioneer and recognized worldwide, Dr. Shepard has received the 2019 Albert Lasker Award and the Warren Alpert Prize, among many other professional accolades.

Sir Marc Feldmann

Sir Marc Feldmann, M.D. Ph.D.

Director & Co-founder

  • Sir Marc Feldmann is a preeminent immunologist, and an Emeritus Professor at the University of Oxford.
  • With Sir Ravinder Maini, identified TNF as a target. Trials of Infliximab (Remicade) they led were successful, and prompted J&J’s $4.9B USD acquisition of Centocor.
  • Anti-TNF sales > $50B USD globally.
  • Professor Sir Marc Feldmann is a Fellow of the Royal Society , of Australian Academy and a Foreign Member of the US National Academy of Sciences; he was knighted in 2010 and received the Australian equivalent.
  • He has received many accolades including the Albert Lasker Award, the Crafoord Prize, the Canada Gairdner Award, the Paul Janssen Award, the Ernst Schering Award.